Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Genomics

Figure 1

From: A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests

Figure 1

Phenotype of MUTZ-3 cells prior to stimulation with sensitizing and non-sensitizing chemicals. Cell surface expression levels of CD14, CD1a, CD34, CD54, CD80, CD86 and HLA-DR were assessed with flow cytometry. Gates were set to exclude debris and dead cells, and quadrants were established by comparing with relevant isotype controls. Results are shown from one representative experiment out of six.

Back to article page